Inicio・Lista de Acciones・Pacific Biosciences of California Inc

Pacific Biosciences of California Inc

Cerrado

SectorSanidad

1.3 1.56

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.27

Máximo

1.31

Métricas clave
By Trading Economics
Ingresos	-45M -53M
Ventas	1.8M 39M
BPA	-0.14
Margen de beneficios	-135.914
Empleados	485
EBITDA	-32M -38M

Dividendos
By Acuity
Próximas Ganancias	4 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-21M 420M
Apertura anterior	-0.26
Cierre anterior	1.3

Noticias sobre sentimiento de mercado

By Acuity

50%

136 / 339 Clasificación en Healthcare

Pacific Biosciences of California Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

11 sept 2026, 19:02 UTC

Pacific Biosciences of California is trading higher, continuing its recovery after three sessions of declines. No specific news was identified for the upward movement.

9 sept 2026, 20:01 UTC

News

Pacific Biosciences of California shares are lower after UBS initiated coverage with a Neutral rating and a price target of $1.35.

8 sept 2026, 23:56 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, despite fluctuations, and remain above their 20-day moving average.

3 sept 2026, 19:56 UTC

Pacific Biosciences of California is lower today with no specific news. The broader market sees falling Treasury yields amid jobless claims data.

2 sept 2026, 23:46 UTC

Pacific Biosciences of California is higher in after-market trading, despite no specific news, amid a weaker ADP payrolls report that may ease rate hike concerns.

1 sept 2026, 23:46 UTC

Pacific Biosciences of California remained roughly flat during after-market hours. This follows five consecutive sessions of lower finishes.

31 ago 2026, 20:07 UTC

Pacific Biosciences is trading lower, reflecting broader market declines amid heightened interest rate hike expectations from the Jackson Hole Economic Symposium.

28 ago 2026, 23:36 UTC

Pacific Biosciences is trading higher in after-market hours, reaching a level significantly above Friday's close amid broader market pressures from rising Treasury yields.

27 ago 2026, 20:07 UTC

Pacific Biosciences of California is lower today, with no specific news driving the decline. The broader market has also been down since Wednesday.

26 ago 2026, 23:06 UTC

Pacific Biosciences of California traded roughly flat in after-market hours, with no specific news driving the activity. The stock remains near its one-month range's upper end.

25 ago 2026, 23:01 UTC

Pacific Biosciences is lower in after-market trading, with no specific news identified. The broader market has also retreated amid falling crude oil prices.

24 ago 2026, 23:01 UTC

Pacific Biosciences of California is trading higher in after-hours, recovering from an initial low and remaining above its 20-day moving average.

21 ago 2026, 22:51 UTC

Correlated Moves

Shares of Pacific Biosciences of California declined in after-market trading, continuing a downward trend amid broader market weakness and rising Treasury yields.

20 ago 2026, 19:51 UTC

Correlated Moves

Pacific Biosciences is lower today, reflecting broader market declines and trading near the lower end of its one-month range.

19 ago 2026, 23:11 UTC

Correlated Moves

Pacific Biosciences of California shows a modest increase in after-market trading, reflecting stability amid a broader positive trend in correlated assets.

18 ago 2026, 23:16 UTC

Correlated Moves

Pacific Biosciences shares declined in after-hours trading, continuing a downward trend since Tuesday's close, amid broader market sentiment reflected by the Russell 2000 Index.

17 ago 2026, 19:11 UTC

News

Pacific Biosciences reported second-quarter revenue of $39 million, with shares trading higher today after initially dropping. The company is undergoing a leadership transition.

14 ago 2026, 19:36 UTC

Correlated Moves

News

Pacific Biosciences reported second-quarter revenue of $39.01 million, missing estimates. Shares are trading lower amid concerns over funding constraints and adoption challenges.

13 ago 2026, 23:06 UTC

Correlated Moves

Pacific Biosciences of California Inc. gained modestly in after-market trading, reflecting broader market trends seen in correlated assets.

12 ago 2026, 23:41 UTC

Pacific Biosciences shares are lower in after-market hours, trading below their 20-day moving average amid easing inflation concerns and broader market conditions.

11 ago 2026, 20:06 UTC

Pacific Biosciences of California is trading higher in a routine session. The stock remains below its 20-day moving average despite today's gains.

10 ago 2026, 23:21 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, recovering from earlier losses and gaining since Monday's close.

7 ago 2026, 22:56 UTC

Correlated Moves

Pacific Biosciences shares are lower in after-market trading, retracing from an initial gain as 10X Genomics declines, impacting market sentiment.

6 ago 2026, 23:11 UTC

Pacific Biosciences of California is higher in after-market trading, reflecting positive momentum since Thursday's close, despite being below its 20-day moving average.

5 ago 2026, 23:01 UTC

News

Pacific Biosciences reported lower second-quarter revenue and a wider EPS loss, prompting a reduction in full-year sales guidance. Shares are down in after-market trading.

4 ago 2026, 21:36 UTC

Pacific Biosciences of California remained roughly flat after market hours. Broader market gains were driven by a decline in crude oil prices.

3 ago 2026, 23:36 UTC

Pacific Biosciences of California Inc. shares are roughly flat after-market, remaining near the lower end of their one-month trading range.

31 jul 2026, 19:46 UTC

News

Correlated Moves

Pacific Biosciences of California is trading lower amid a report citing annual sales declines and cash burn concerns impacting its growth outlook.

29 jul 2026, 16:06 UTC

Correlated Moves

Pacific Biosciences of California Inc shares are lower today, reflecting broader market pressure on small-cap equities and a notable decline in correlated assets.

28 jul 2026, 16:12 UTC

Pacific Biosciences is trading higher, rebounding from earlier losses despite broader market caution following declines in the Nikkei 225 Index.

Comparación entre iguales

Cambio de precio

Pacific Biosciences of California Inc previsión

Consenso

By TipRanks

Neutral

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Pacific Biosciences of California Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

136 / 339 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.